Anti-Yersinia antibodies are not associated with microscopic colitis in an American case-control study

Cyrus P Tamboli1, Meredith R Good, Erin M Reynolds

  • 1Department of Internal Medicine, University of Iowa, IA, USA. cyrus-tamboli@uiowa.edu

Abstract

Insights

This study found no evidence that Yersinia enterocolitica infection triggers microscopic colitis (MC) in American patients. Researchers did not detect a link between Yersinia antibodies and MC development in this case-control investigation.

Area of Science:

  • Gastroenterology
  • Immunology
  • Infectious Diseases

Background:

  • Microscopic colitis (MC), encompassing lymphocytic colitis and collagenous colitis, is potentially linked to gastrointestinal infections.
  • Previous research suggests a possible association between MC and Yersinia enterocolitica infection.

Purpose of the Study:

  • To investigate the hypothesis that Yersinia enterocolitica infection may trigger microscopic colitis in American patients.
  • To examine the seroprevalence of antibodies against Yersinia enterocolitica in MC patients compared to healthy controls.

Main Methods:

  • A case-control study was conducted with 47 MC patients and 44 matched healthy controls.
  • Serum samples were analyzed for anti-Yersinia enterocolitica IgA and IgG antibodies using ELISA.
  • Fisher's exact test was employed for statistical significance assessment.

Main Results:

  • No significant differences in the seroprevalence of anti-Yersinia IgA or IgG antibodies were observed between MC patients and controls.
  • The prevalence rates for IgA antibodies were 2.1% in cases and 2.3% in controls (p = 1.00).
  • The prevalence rates for IgG antibodies were 4.3% in cases and 6.8% in controls (p = 0.67).
  • No correlation was found between antibody titers and the duration of MC diagnosis.

Conclusions:

  • The study's findings do not support a role for Yersinia enterocolitica exposure in the development of microscopic colitis among the studied American population.
  • Further research may be needed to explore other potential infectious triggers for microscopic colitis.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...